These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11776335)

  • 1. The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis.
    Smorenburg SM; Vink R; Otten HM; Swaneveld F; Büller HR
    Thromb Haemost; 2001 Dec; 86(6):1586-7. PubMed ID: 11776335
    [No Abstract]   [Full Text] [Related]  

  • 2. A rebuttal: vitamin K antagonists and cancer survival.
    Zacharski LR; Henderson WG
    Thromb Haemost; 2002 Jul; 88(1):173-4; author reply 175. PubMed ID: 12152670
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical studies with anticoagulants to improve survival in cancer patients.
    Gerotziafas GT; Papageorgiou C; Hatmi M; Samama MM; Elalamy I
    Pathophysiol Haemost Thromb; 2008; 36(3-4):204-11. PubMed ID: 19176993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of unfractionated heparin on survival in patients with malignancy--a systematic review.
    Smorenburg SM; Hettiarachchi RJ; Vink R; Büller HR
    Thromb Haemost; 1999 Dec; 82(6):1600-4. PubMed ID: 10613641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin in tumor progression and metastatic dissemination.
    Falanga A; Marchetti M
    Semin Thromb Hemost; 2007 Oct; 33(7):688-94. PubMed ID: 18000796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep vein thrombosis and cancer: survival, recurrence, and anticoagulant choices.
    Lee AY
    Dis Mon; 2005; 51(2-3):150-7. PubMed ID: 15900267
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of oral anticoagulants in tumor biology.
    Weitz IC; Liebman HA
    Semin Thromb Hemost; 2007 Oct; 33(7):695-8. PubMed ID: 18000797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants.
    Büller HR; Halperin JL; Bounameaux H; Prins M
    J Thromb Haemost; 2008 Feb; 6(2):227-9. PubMed ID: 18034770
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of venous thrombosis in cancer patients: practical aspects].
    Laza-Achille M; Desruennes E; Di Palma M
    Bull Cancer; 2006 Mar; 93(3):271-81. PubMed ID: 16567314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New anticoagulants: an update.
    Crowther M; Weitz JI
    Clin Adv Hematol Oncol; 2004 Nov; 2(11):743-9. PubMed ID: 16170892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development in anticoagulant therapy.
    van Doormaal FF; Büller HR; Middeldorp S
    Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Initial trials give hope. Anticoagulants against cancer?].
    Hiller E
    MMW Fortschr Med; 2003 Apr; 145(14):16. PubMed ID: 15072270
    [No Abstract]   [Full Text] [Related]  

  • 14. Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.
    Bozcuk H; Artac M; Ozdogan M; Savas B
    Cancer; 2005 Dec; 104(12):2650-7. PubMed ID: 16284984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
    Tay KH; Lip GY; Lane DA
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
    [No Abstract]   [Full Text] [Related]  

  • 16. Warfarin and the antiphospholipid syndrome: does one size fit all?
    Kasthuri RS; Roubey RA
    Arthritis Rheum; 2007 Dec; 57(8):1346-7. PubMed ID: 18050224
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
    MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring the effects and managing the side effects of anticoagulation during pregnancy.
    Gris JC; Lissalde-Lavigne G; Quére I; Marés P
    Obstet Gynecol Clin North Am; 2006 Sep; 33(3):397-411. PubMed ID: 16962917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin-antivitamin K transfer].
    Fiessinger JN; Aïach M
    Rev Prat; 1988 May; 38(15):944, 947-51. PubMed ID: 3393836
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.